Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Study of Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin in Patients with Type 2 Diabetes Mellitus

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)(2013)10.5649/jjphcs.39.309Source: DataRank Database

Study of Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin in Patients with Type 2 Diabetes Mellitus is a research paper published in Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) (2013). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Pending

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Kenichiro Hayashi,Masayuki Yamakawa,Toshiyuki Kokuryo